Sonnet BioTherapeutics Holdings has made headlines in the crypto space, as the firm earlier announced that it had merged with Hyperliquid Strategies Inc. to establish a digital asset treasury for the HYPE crypto. According to the announcement, the treasury will hold $888 million. This makes it one of the largest crypto initiatives in recent times. The latest report also disclosed that roughly 65% of the treasury will be allocated in HYPE tokens, and approximately 35% will be committed in United States dollars. More Corporate Crypto Treasury Strategies Despite the continuous downtrend in the broader crypto market, the latest development reflects the firm’s commitment to digital assets while still reserving a portion of USD for stability. The recent move underscores the growing trend of non-financial entities exploring crypto as a core part of their corporate treasury strategies. The initiative is no longer new in the crypto space. While tech and financial companies earlier adopted this move, Sonnet BioTherapeutics Holdings shows that its sector wouldn’t be left out. Firms in the biotech and healthcare sectors are starting to explore the value in crypto assets. Although Nasdaq-listed healthcare tech firm Semler Scientific (SMLR) has already begun exploring digital assets. The decision to create the treasury received strong shareholder backing. After the shareholders voted, the proposal was officially approved. With this latest approval, the firm can plan how to manage and grow its digital asset reserve. Hyperliquid Strategies to Manage Sonnet’s HYPE Treasury Hyperliquid Strategies Inc., the partner in the latest development, known for offering crypto-focused guidelines and asset management services. They will help the biotech company in managing the HYPE treasury. Hyperliquid will also assist the firm in navigating market swings and risks often associated with crypto assets. By committing a significant portion of the treasury to HYPE tokens, Sonnet BioTherapeutics sees potential in the token. It shows strong confidence in the asset while keeping a notable portion in the United States dollars. The move will likely catch the eye of several investors. It shows that more companies are starting to blend regular finance with digital assets. Meanwhile, following the announcement, HYPE token traded at $33.9. It represents an 8.8% increase in the last 24 hours, according to data from CoinGecko. The post Sonnet Bio Merges With Hyperliquid, Creates $888M HYPE Treasury appeared first on CoinTab News.Sonnet BioTherapeutics Holdings has made headlines in the crypto space, as the firm earlier announced that it had merged with Hyperliquid Strategies Inc. to establish a digital asset treasury for the HYPE crypto. According to the announcement, the treasury will hold $888 million. This makes it one of the largest crypto initiatives in recent times. The latest report also disclosed that roughly 65% of the treasury will be allocated in HYPE tokens, and approximately 35% will be committed in United States dollars. More Corporate Crypto Treasury Strategies Despite the continuous downtrend in the broader crypto market, the latest development reflects the firm’s commitment to digital assets while still reserving a portion of USD for stability. The recent move underscores the growing trend of non-financial entities exploring crypto as a core part of their corporate treasury strategies. The initiative is no longer new in the crypto space. While tech and financial companies earlier adopted this move, Sonnet BioTherapeutics Holdings shows that its sector wouldn’t be left out. Firms in the biotech and healthcare sectors are starting to explore the value in crypto assets. Although Nasdaq-listed healthcare tech firm Semler Scientific (SMLR) has already begun exploring digital assets. The decision to create the treasury received strong shareholder backing. After the shareholders voted, the proposal was officially approved. With this latest approval, the firm can plan how to manage and grow its digital asset reserve. Hyperliquid Strategies to Manage Sonnet’s HYPE Treasury Hyperliquid Strategies Inc., the partner in the latest development, known for offering crypto-focused guidelines and asset management services. They will help the biotech company in managing the HYPE treasury. Hyperliquid will also assist the firm in navigating market swings and risks often associated with crypto assets. By committing a significant portion of the treasury to HYPE tokens, Sonnet BioTherapeutics sees potential in the token. It shows strong confidence in the asset while keeping a notable portion in the United States dollars. The move will likely catch the eye of several investors. It shows that more companies are starting to blend regular finance with digital assets. Meanwhile, following the announcement, HYPE token traded at $33.9. It represents an 8.8% increase in the last 24 hours, according to data from CoinGecko. The post Sonnet Bio Merges With Hyperliquid, Creates $888M HYPE Treasury appeared first on CoinTab News.
Sonnet Bio Merges With Hyperliquid, Creates $888M HYPE Treasury
Sonnet BioTherapeutics Holdings has made headlines in the crypto space, as the firm earlier announced that it had merged with Hyperliquid Strategies Inc. to establish a digital asset treasury for the HYPE crypto.
According to the announcement, the treasury will hold $888 million. This makes it one of the largest crypto initiatives in recent times. The latest report also disclosed that roughly 65% of the treasury will be allocated in HYPE tokens, and approximately 35% will be committed in United States dollars.
More Corporate Crypto Treasury Strategies
Despite the continuous downtrend in the broader crypto market, the latest development reflects the firm’s commitment to digital assets while still reserving a portion of USD for stability.
The recent move underscores the growing trend of non-financial entities exploring crypto as a core part of their corporate treasury strategies. The initiative is no longer new in the crypto space.
While tech and financial companies earlier adopted this move, Sonnet BioTherapeutics Holdings shows that its sector wouldn’t be left out. Firms in the biotech and healthcare sectors are starting to explore the value in crypto assets. Although Nasdaq-listed healthcare tech firm Semler Scientific (SMLR) has already begun exploring digital assets.
The decision to create the treasury received strong shareholder backing. After the shareholders voted, the proposal was officially approved. With this latest approval, the firm can plan how to manage and grow its digital asset reserve.
Hyperliquid Strategies to Manage Sonnet’s HYPE Treasury
Hyperliquid Strategies Inc., the partner in the latest development, known for offering crypto-focused guidelines and asset management services. They will help the biotech company in managing the HYPE treasury. Hyperliquid will also assist the firm in navigating market swings and risks often associated with crypto assets.
By committing a significant portion of the treasury to HYPE tokens, Sonnet BioTherapeutics sees potential in the token. It shows strong confidence in the asset while keeping a notable portion in the United States dollars.
The move will likely catch the eye of several investors. It shows that more companies are starting to blend regular finance with digital assets. Meanwhile, following the announcement, HYPE token traded at $33.9. It represents an 8.8% increase in the last 24 hours, according to data from CoinGecko.
The post Sonnet Bio Merges With Hyperliquid, Creates $888M HYPE Treasury appeared first on CoinTab News.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
You May Also Like
When Is ‘Five Nights At Freddy’s 2’ Coming To Streaming?
The post When Is ‘Five Nights At Freddy’s 2’ Coming To Streaming? appeared on BitcoinEthereumNews.com. Mike (Josh Hutcherson) and Balloon Boy in “Five Nights at Freddy’s 2.” Universal Pictures/Ryan Green The horror thriller Five Nights at Freddy’s 2 is new in theaters. How soon will the second movie adaptation of the blockbuster video game be available to stream at home? Rated PG-13, Five Nights at Freddy’s 2 opened in theaters nationwide on Friday. The official synopsis for the film reads, “One year has passed since the supernatural nightmare at Freddy Fazbear’s Pizza. The stories about what transpired there have been twisted into a campy local legend, inspiring the town’s first-ever Fazfest. ForbesRotten Tomatoes Critics Crush ‘Five Nights At Freddy’s 2’By Tim Lammers Former security guard Mike (Josh Hutcherson) and police officer Vanessa (Elizabeth Lail) have kept the truth from Mike’s 11-year-old sister, Abby (Piper Rubio), concerning the fate of her animatronic friends. But when Abby sneaks out to reconnect with Freddy, Bonnie, Chica, and Foxy, it will set into motion a terrifying series of events, revealing dark secrets about the true origin of Freddy’s, and unleashing a long-forgotten horror hidden away for decades.” Directed by Emma Tammi, Five Nights at Freddy’s 2 also stars Theodus Crane and Matthew Lillard as William Afton, as well as the voices of Freddy Carter, Wayne Knight, Mckenna Grace and Skeet Ulrich. ForbesHow Soon Will ‘Chainsaw Man – The Movie: Reze Arc’ Arrive On Streaming?By Tim Lammers The first place Five Nights at Freddy’s 2 will be available in the home entertainment marketplace is digital streaming via premium video on demand. Generally, Five Nights at Freddy’s 2’s studio, Universal Pictures (and its subsidiary Focus Features), releases its films on digital streaming via premium video on demand anywhere from 18 days to a month after they open in theaters. For example, Universal’s crime comedy Nobody 2 opened in theaters on Aug.…
Share
BitcoinEthereumNews2025/12/06 09:55
STRF Has Performed Best During the Recent Bounce
The post STRF Has Performed Best During the Recent Bounce appeared on BitcoinEthereumNews.com. Strategy’s (MSTR) senior perpetual preferred stock, STRF, is increasingly standing out as the company’s most successful credit instrument since its launch in March. Trading at $110, STRF has risen 36% from issuance and has rebounded 20% from its Nov. 21 low of $92. That date also marked bitcoin’s local bottom near $80,000, highlighting the strong correlation between STRF and bitcoin. STRF occupies the top tier of Strategy’s preferred structure. It pays a fixed 10% annual cash dividend and features governance rights plus penalty based step ups if payments are missed. Even with its premium pricing pushing the effective yield down to about 9.03%, demand remains strong due to the security’s senior protections and long duration credit profile. In late October, executive chairman Michael Saylor highlighted a growing credit spread between STRF and the junior STRD. The spread measures the extra yield investors demand to hold higher risk junior securities, which is now at 12.5%. At the Nov. 21 low, that differential widened to an all time high of 1.5 as investors crowded into senior exposure, STRD was trading as low as $65. The spread has since normalized to around 1.3. Divergence is now visible across Strategy’s preferred suite. STRC, has seen four dividend rate increases to sustain investor interest. Strategy’s equity has also rebounded, climbing from a Dec 1 low of $155 to about $185, reflecting improved sentiment across both the company’s balance sheet and the bitcoin market since announcing a $1.44 billion cash buffer resevere for the preferred dividend payments. Source: https://www.coindesk.com/markets/2025/12/05/strf-emerges-as-strategy-s-standout-credit-instrument-after-nine-months-of-trading
Share
BitcoinEthereumNews2025/12/06 10:11
BTC supply on centralized exchanges is at a 7-year low
PANews reported on September 18th that crypto analyst The DeFi Investor wrote on the X platform: "The supply of BTC on centralized exchanges is at its lowest level in seven years. The scale of funds invested by institutions in purchasing Bitcoin in this cycle is incredible."
Share
PANews2025/09/18 09:53